INNO-GENE SA ZY -10 Financial Flexibility Index
INNO-GENE SA ZY -10 financial flexibility index. INNO-GENE SA ZY -10 (WQ3) has a Financial Flexibility Index of 0.09x as of June 2025. Free cash flow of €704.00K (operating CF €54.00K minus capex €650.00K) represents 0% of total liabilities (€7.45 Million). See WQ3 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of INNO-GENE SA ZY -10 (2021–2024)
Financial flexibility index of INNO-GENE SA ZY -10 from 2021 to 2024. Historical Financial Flexibility Index trend for INNO-GENE SA ZY -10 across 4 annual periods. Check WQ3 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
INNO-GENE SA ZY -10 Financial Flexibility Index by Year (2021–2024)
INNO-GENE SA ZY -10 financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for INNO-GENE SA ZY -10. For the full cash flow conversion analysis, see WQ3 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.17x | €-1.09 Million | €-1.13 Million | €6.50 Million | ▲ +78.8% |
| 2023 | -0.79x | €-2.49 Million | €-2.49 Million | €3.16 Million | ▼ -15993.0% |
| 2022 | 0.00x | €11.00K | €11.00K | €2.22 Million | ▼ -99.6% |
| 2021 | 1.22x | €6.83 Million | €6.75 Million | €5.60 Million | — |